Tarsus Pharmaceuticals, Inc. TARS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $186.2M+91.2% | $97.38M-56.7% | $224.95M+214% | $71.66M-58.2% | ||
| $233.63M+18.9% | $196.56M+7,778% | $2.5M-98.3% | $145.37M+29,996% | ||
| $278.44M+106% | $135.33M+516% | $21.98M+43,004% | $51K-99.8% | ||
| $2.53M0.0% | $2.53M— | $0— | $0— | ||
| $522.78M+46.6% | $356.71M+39.3% | $256.13M+13.6% | $225.38M+28.1% | ||
| $11.67M+404% | $2.31M+57.6% | $1.47M+53.4% | $957K+26.8% | ||
| $7.37M-11.5% | $8.33M+115% | $3.87M+30.2% | $2.97M-0.5% | ||
| $562.16M+49.1% | $376.99M+42.0% | $265.49M+16.5% | $227.86M+27.4% | ||
| $16.39M+74.0% | $9.42M-47.0% | $17.77M+223% | $5.5M+92.5% | ||
| $135.7M+68.3% | $80.61M+118% | $36.94M+139% | $15.43M+34.4% | ||
| $72.44M+0.8% | $71.85M+141% | $29.82M+53.4% | $19.43M— | ||
| $218.73M+43.5% | $152.46M+123% | $68.5M+95.9% | $34.96M+187% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$426.63M-18.4% | -$360.21M-47.2% | -$244.66M-125% | -$108.76M-133% | ||
| $343.43M+53.0% | $224.53M+14.0% | $196.99M+2.1% | $192.9M+15.7% | ||
| $562.16M+49.1% | $376.99M+42.0% | $265.49M+16.5% | $227.86M+27.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tarsus Pharmaceuticals, Inc.'s total assets?
- Tarsus Pharmaceuticals, Inc. (TARS) holds $581.1M in total assets, up 16.1% year over year.
- How much debt does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. carries $88.7M in total debt against $349.0M of shareholders' equity, a debt-to-equity ratio of 0.25.
- How much cash does Tarsus Pharmaceuticals, Inc. have?
- Tarsus Pharmaceuticals, Inc. holds $104.2M in cash and equivalents.
- Can Tarsus Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.74 — current assets exceed current liabilities.
- Where does Tarsus Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
